Safety and Tolerability of WVE-210201 in Patients With Duchenne Muscular Dystrophy
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Michael A Panzara, MD, MPH
Wave Life Sciences USA, Inc.
Study Director
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
13 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Uz Gent
Ghent, Belgium
- Universitaire Ziekenhuizen Leuven
Leuven, Belgium
- Chr de la Citadelle
Liège, Belgium
- London Health Sciences Centre - Hospital
London, Ontario, Canada
- Hôpital Armand Trousseau
Paris, France
- U.O.C Di Neurologia E Malattie Neuromuscolari Centro Clinico Nemo Sud
Messina, Italy
- U.O. Immunologia Pediatrica
Milan, Italy
- Radbound University Nijmegen Medical Care
Nijmegen, Netherlands
- University Hospitals Bristol Nhs Foundation Trust
Bristol, United Kingdom
- Alder Hey Children'S Hospital
Liverpool, United Kingdom
- Evelina London Children'S Hospital
London, United Kingdom
- Ucl Institute of Child Health & Great Ormond Street Hospital for Children
London, United Kingdom
- Rare Disease Research, Llc.
Atlanta, Georgia, United States
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 24 Jan 2018
- Primary completion
- 6 Mar 2019
- Completion
- 6 Mar 2019
- Last update posted
- 8 Apr 2019
- Registered enrollment
- 36
- Registry id
- NCT03508947
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.